Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: A report from the International Neuroblastoma Risk Group Project

European Journal of Cancer

Volumn 47, Issue 4, 2011, Pages 561-571

  Moroz, Veronica ^a   MacHin, David ^a   Faldum, Andreas ^b   Hero, Barbara ^c   Iehara, Tomoko ^d   Mosseri, Veronique ^e   Ladenstein, Ruth ^f   Bernardi, Bruno De ^g   Rubie, Hervé ^h   Berthold, Frank ^c   Matthay, Katherine K ⁱ   Monclair, Tom ^j   Ambros, Peter F ^k   Pearson, Andrew D J ^l   Cohn, Susan L ^m   London, Wendy B ⁿ  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e INSTITUT CURIE   (France)

^f ST ANNA CHILDREN S HOSPITAL   (Austria)

^g G GASLINI INSTITUTE   (Italy)

^h HÔPITAL DES ENFANTS   (France)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j OSLO UNIVERSITY HOSPITAL   (Norway)

^k CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^l INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^m UNIVERSITY OF CHICAGO   (United States)

ⁿ BOSTON CHILDREN S HOSPITAL   (United States)

more..

Author keywords

Age at diagnosis; INRG; Neuroblastoma; Outcome; Prognosis

Indexed keywords

MYC PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW METASTASIS; CANCER MORTALITY; CHILD; EVENT FREE SURVIVAL; GENE AMPLIFICATION; GROUPS BY AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEUROBLASTOMA; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SURVIVAL TIME;

ADOLESCENT; AGE DISTRIBUTION; AGE OF ONSET; AUSTRALIA; BONE MARROW NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; EUROPE; HUMANS; INFANT; JAPAN; NEUROBLASTOMA; NORTH AMERICA; PROGNOSIS; RISK FACTORS;

EID: 79851512935     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.10.022     Document Type: Article

References (16)

1. N. Breslow, and B. McCann Statistical estimation of prognosis for children with neuroblastoma Cancer Res 31 1971 2098 2103
2. A.E. Evans Staging and treatment of neuroblastoma Cancer 45 1980 1799 1802 (Pubitemid 10153627)
3. G.M. Brodeur Neuroblastoma: biological insights into a clinical enigma Nat Rev Cancer 3 2003 203 216 (Pubitemid 37328872)
4. G. Cecchetto, V. Mosseri, and B. De Bernardi Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group J Clin Oncol 23 2005 8483 8489
5. B.H. Kushner, and S.L. Cohn Intermediate-risk Neuroblastoma N.-K.V. Cheung, S.L. Cohn, Neuroblastoma 2005 Springer-Verlag Heidelberg 131 137
6. E.F. Attiyeh, W.B. London, and Y.P. Mosse Chromosome 1p and 11q deletions and outcome in neuroblastoma N Engl J Med 353 2005 2243 2253 (Pubitemid 41697287)
7. H. Caron, P. van Sluis, and J. de Kraker Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma N Engl J Med 334 1996 225 230 (Pubitemid 26030673)
8. N. Bown, S. Cotterill, and M. Lastowska Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma N Engl J Med 340 1999 1954 1961 (Pubitemid 29288271)
9. S.L. Cohn, A.D.J. Pearson, and W.B. London The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report J Clin Oncol 27 2009 289 297
10. D.R. Cox Regression models and life-tables J Royal Stat Soc (B) 34 1972 187 220
11. D. Machin, Y.-B. Cheung, and M.K.B. Parmar Survival analysis: a practical approach 2006 John Wiley Chichester
12. G.M. Brodeur, J. Pritchard, and F. Berthold Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment J Clin Oncol 11 1993 1466 1477 (Pubitemid 23228250)
13. T. Monclair, G.M. Brodeur, and P.F. Ambros The International Neuroblastoma Risk Group (INRG) Staging System J Clin Oncol 27 2009 298 303
14. StataCorp. Stata Statistical Software: Release 10.0. College Station. Texas: Stata Press; 2007.
15. W.B. London, R.P. Castleberry, and K.K. Matthay Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group J Clin Oncol 27 2005 6459 6465 (Pubitemid 46190236)
16. K.K. Matthay, J.G. Villablanca, and R.C. Seeger Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous BM transplantation, and 13-cis-retinoic acid. Children's Cancer Group N Engl J Med 341 1999 1165 1173 (Pubitemid 29480654)